Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Review for Medical and Pharmacological Sciences|August 2, 2021
Endocannabinoid system expression in ovarian epithelial tumors according to the dualistic model of ovarian carcinogenesisA Ronchi, F Grauso, F Zito Marino, et al.
European Review for Medical and Pharmacological Sciences|September 26, 2023
Mindfulness-based stress reduction in cancer patients: impact on overall survival, quality of life and risk factorP Forte, V Abate, I Bolognini, et al.
Frontiers in Pharmacology|July 5, 2022
Improved Survival and Quality of Life Through an Integrative, Multidisciplinary Oncological Approach: Pathophysiological Analysis of Four Clinical Cancer Cases and Review of the LiteratureM Berretta, A Morra, R Taibi, et al.
European Review for Medical and Pharmacological Sciences|June 10, 2021
Reasons why COVID-19 survivors should follow dietary World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) recommendations: from hyper-inflammation to cardiac dysfunctionsV Quagliariello, G D'Aiuto, R V Iaffaioli, et al.
International Journal of Cardiology|June 5, 2019
Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to TrastuzumabV Quagliariello, M Passariello, C Coppola, et al.
Frontiers in Cardiovascular Medicine|February 7, 2024
Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncologyV Quagliariello, M Passariello, I Bisceglia, et al.
Nature Communications|September 8, 2023
Fasting mimicking diet in mice delays cancer growth and reduces immunotherapy-associated cardiovascular and systemic side effectsS Cortellino, V Quagliariello, G Delfanti, et al.
Frontiers in Cardiovascular Medicine|May 31, 2024
Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicityV Quagliariello, M L Canale, I Bisceglia, et al.
Cardio-Oncology (London, England)|September 2, 2025
SGLT2i Dapagliflozin in primary prevention of chemotherapy induced cardiotoxicity in breast cancer patients treated with neo-adjuvant anthracycline-based chemotherapy +/- trastuzumab: rationale and design of the multicenter PROTECT trialA Greco, V Quagliariello, G Rizzo, et al.
Pageof 2